Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advancis, a pharmaceutical company focused on anti-infective products, has launched a higher dose of its antibiotic Keflex capsules.
Subscribe to our email newsletter
“With the availability of Keflex 750mg capsules, physicians and other healthcare professionals will be able to deliver a total daily dose of Keflex with fewer capsules per day,” said Dr Edward Rudnic, president and CEO of Advancis.
Keflex 750mg capsules have been manufactured, packaged, and are currently being distributed to pharmacies across the US in bottles of 50.
Advancis’ sales representatives are soon expected to begin directly promoting Keflex 750mg to targeted physicians as well as providing patient starter samples. The company expects to see measurable Keflex 750mg prescription volume beginning the week of July 31, 2006.
Advancis acquired the rights to manufacture, market, and sell Keflex in the US in July of 2004. Keflex is the number one most prescribed oral cephalosporin antibiotic and is also the number one recommended oral antibiotic therapy for uncomplicated skin and skin structure infections. Advancis received approval for introduction of the Keflex 750mg capsules in May 2006.